---
layout: default
permalink: /people/marleen/
---

<h2>Marleen van Gelder</h2>

<div class="row">
    <div class="col-8">
        <br>
      <p>Dr. Marleen van Gelder is Assistant Professor in Pharmacoepidemiology at the Radboudumc and Researcher in Biostatistics and Pharmacoepidemiology at the University of Oslo. Her research focuses on using observational data to gain more insight into the safety of medication use, in particular in populations in which trials are often not feasible (pregnant people, children). Her interests include improving exposure and outcome assessment, embracing longitudinal patterns, as well as causal inference methodology. She is currently chair of the Special Interest Group “Medication in Pregnancy and Lactation” of the Internationl Society for PharmacoEpidemiology (ISPE) and member of the Subcommittee on the Classification of Substances Toxic to Reproduction of the Health Council of the Netherlands.
        </p>
    </div>
    <div class="col-4">
        <img class="card-img-top" src="/assets/pictures/people/Marleen.JPG" alt="" style="width:60%"/>
    </div>
</div>

  
<br>
<br> 

### Key publications

- Schreuder A, Mokadem I, Smeets NJL, Spaanderman MEA, Roeleveld N, Lupattelli A, **van Gelder MMHJ.**, Associations of periconceptional oral contraceptive use with pregnancy complications and adverse birth outcomes. Int J Epidemiol. 2023; 52: 1388-1399. DOI: 10.1093/ije/dyad045.
- **van Gelder MMHJ**, Donders ART, Devine O, Roeleveld N, Reefhuis J. Using Bayesian models to assess the effects of underreporting of cannabis use on the association with birth defects, National Birth Defects Prevention Study, 1997–2005. Paediatr Perinat Epidemiol 2014; 28: 424-433. DOI: 10.1111/ppe.12140.
- **van Gelder MMHJ**, Bretveld RW, Roeleveld N. Web-based questionnaires: the future in epidemiology? Am J Epidemiol 2010; 172: 1292-1298. DOI: 10.1093/aje/kwq291.
- Wood ME, Lupattelli A, Palmsten K, Bandoli G, Hurault-Delarue C, Damase-Michel C, Chambers CH, Nordeng HME, **van Gelder MMHJ.**, Longitudinal methods for modeling exposures in pharmacoepidemiologic studies in pregnancy. Epidemiol Rev 2021; 43: 130-146. DOI: 10.1093/epirev/mxab002.



<br>
<br>
<p>E: Marleen.vanGelder - at - radboudumc.nl</p>
<p><a href="https://scholar.google.nl/citations?hl=nl&user=ht7BMqYAAAAJ">Google Scholar</a>  | <a href="www.linkedin.com/in/marleenvangelder">LinkedIn</a> </p>  












